0.910
0.91 (0%)
As of Dec 20, 2024
Genprex, Inc. [GNPX]
Source:
Company Overview
Genprex, Inc is a clinical stage gene therapy company pioneering the development of gene-based therapies for large patient populations with unmet medical needs. Our oncology platform utilizes our non-viral ONCOPREX Nanoparticle Delivery System.
| Country | United States |
| Headquarters | austin, texas |
| Phone Number | 512-537-7997 |
| Industry | manufacturing |
| CEO | J. Rodney Varner |
| Website | genprex.com |